Characterization of Volatile Organic Compound Metabolites in Cigarette Smokers, Electronic Nicotine Device Users, Dual Users, and Nonusers of Tobacco

Abstract Introduction Limited research exists about the possible cardiovascular effects of electronic nicotine delivery systems (ENDS). We therefore sought to compare exposure to known or potentially cardiotoxic volatile organic compounds (VOCs) in ENDS users, smokers, and dual users. Methods A tota...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nicotine & tobacco research 2020-02, Vol.22 (2), p.264-272
Hauptverfasser: Keith, Rachel J, Fetterman, Jessica L, Orimoloye, Olusola A, Dardari, Zeina, Lorkiewicz, Pawel K, Hamburg, Naomi M, DeFilippis, Andrew P, Blaha, Michael J, Bhatnagar, Aruni
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 272
container_issue 2
container_start_page 264
container_title Nicotine & tobacco research
container_volume 22
creator Keith, Rachel J
Fetterman, Jessica L
Orimoloye, Olusola A
Dardari, Zeina
Lorkiewicz, Pawel K
Hamburg, Naomi M
DeFilippis, Andrew P
Blaha, Michael J
Bhatnagar, Aruni
description Abstract Introduction Limited research exists about the possible cardiovascular effects of electronic nicotine delivery systems (ENDS). We therefore sought to compare exposure to known or potentially cardiotoxic volatile organic compounds (VOCs) in ENDS users, smokers, and dual users. Methods A total of 371 individuals from the Cardiovascular Injury due to Tobacco Use study, a cross-sectional study of healthy participants aged 21–45 years, were categorized as nonusers of tobacco (n = 87), sole ENDS users (n = 17), cigarette smokers (n = 237), and dual users (n = 30) based on 30-day self-reported tobacco product use patterns. Participants provided urine samples for VOC and nicotine metabolite measurement. We assessed associations between tobacco product use and VOC metabolite measures using multivariable-adjusted linear regression models. Results Mean (SD) age of the population was 32 (±6.8) years, 55% men. Mean urinary cotinine level in nonusers of tobacco was 2.6 ng/mg creatinine, whereas cotinine levels were similar across all tobacco product use categories (851.6–910.9 ng/mg creatinine). In multivariable-adjusted models, sole ENDS users had higher levels of metabolites of acrolein, acrylamide, acrylonitrile, and xylene compared with nonusers of tobacco, but lower levels of most VOC metabolites compared with cigarette smokers or dual users. In direct comparison of cigarettes smokers and dual users, we found lower levels of metabolites of styrene and xylene in dual users. Conclusion Although sole ENDS use may be associated with lower VOC exposure compared to cigarette smoking, further study is required to determine the potential health effects of the higher levels of certain reactive aldehydes, including acrolein, in ENDS users compared with nonusers of tobacco. Implications ENDS use in conjunction with other tobacco products may not significantly reduce exposure to VOC, but sole use does generally reduce some VOC exposure and warrants more in-depth studies.
doi_str_mv 10.1093/ntr/ntz021
format Article
fullrecord <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7297089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ntr/ntz021</oup_id><sourcerecordid>10.1093/ntr/ntz021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-39e3bd07603c39e41c847a6971b346079d471e701793d85d6e82878dc4d45c983</originalsourceid><addsrcrecordid>eNp9kb1OwzAUhS0EolBYeADkhQURsGM3jhcklJYfCehAi9gix7kthjSuHKcSvAfvi0uhgoXB8rnyd86VfBA6oOSUEsnOau_CeScx3UA7lCcykpI_bX7pOIpjwjpot2leSCBoSrdRhxHRkzGPd9BH9qyc0h6ceVfe2BrbCX60VdAV4KGbqtponNnZ3LZ1ie_Aq8JWxkODTY0zM1UOvAf8MLOv4JoTPKhAe2eXrnujrTc14D4sjAY8br6IfquqH61C5r2t2-W03DyyhdLa7qGtiaoa2P--u2h8ORhl19Ht8Oomu7iNNBfcR0wCK0oiEsJ00JzqlAuVSEELxhMiZMkFBUGokKxMe2UCaZyKtNS85D0tU9ZF56vceVvMoNQQvlJV-dyZmXJvuVUm__tSm-d8ahe5iKUgqQwBx6sA7WzTOJisvZTky3Ly4MtX5QT48Pe2NfrTRgCOVoBt5_8FfQIB3ZuT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Characterization of Volatile Organic Compound Metabolites in Cigarette Smokers, Electronic Nicotine Device Users, Dual Users, and Nonusers of Tobacco</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Keith, Rachel J ; Fetterman, Jessica L ; Orimoloye, Olusola A ; Dardari, Zeina ; Lorkiewicz, Pawel K ; Hamburg, Naomi M ; DeFilippis, Andrew P ; Blaha, Michael J ; Bhatnagar, Aruni</creator><creatorcontrib>Keith, Rachel J ; Fetterman, Jessica L ; Orimoloye, Olusola A ; Dardari, Zeina ; Lorkiewicz, Pawel K ; Hamburg, Naomi M ; DeFilippis, Andrew P ; Blaha, Michael J ; Bhatnagar, Aruni</creatorcontrib><description>Abstract Introduction Limited research exists about the possible cardiovascular effects of electronic nicotine delivery systems (ENDS). We therefore sought to compare exposure to known or potentially cardiotoxic volatile organic compounds (VOCs) in ENDS users, smokers, and dual users. Methods A total of 371 individuals from the Cardiovascular Injury due to Tobacco Use study, a cross-sectional study of healthy participants aged 21–45 years, were categorized as nonusers of tobacco (n = 87), sole ENDS users (n = 17), cigarette smokers (n = 237), and dual users (n = 30) based on 30-day self-reported tobacco product use patterns. Participants provided urine samples for VOC and nicotine metabolite measurement. We assessed associations between tobacco product use and VOC metabolite measures using multivariable-adjusted linear regression models. Results Mean (SD) age of the population was 32 (±6.8) years, 55% men. Mean urinary cotinine level in nonusers of tobacco was 2.6 ng/mg creatinine, whereas cotinine levels were similar across all tobacco product use categories (851.6–910.9 ng/mg creatinine). In multivariable-adjusted models, sole ENDS users had higher levels of metabolites of acrolein, acrylamide, acrylonitrile, and xylene compared with nonusers of tobacco, but lower levels of most VOC metabolites compared with cigarette smokers or dual users. In direct comparison of cigarettes smokers and dual users, we found lower levels of metabolites of styrene and xylene in dual users. Conclusion Although sole ENDS use may be associated with lower VOC exposure compared to cigarette smoking, further study is required to determine the potential health effects of the higher levels of certain reactive aldehydes, including acrolein, in ENDS users compared with nonusers of tobacco. Implications ENDS use in conjunction with other tobacco products may not significantly reduce exposure to VOC, but sole use does generally reduce some VOC exposure and warrants more in-depth studies.</description><identifier>ISSN: 1462-2203</identifier><identifier>EISSN: 1469-994X</identifier><identifier>DOI: 10.1093/ntr/ntz021</identifier><identifier>PMID: 30759242</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Original Investigations</subject><ispartof>Nicotine &amp; tobacco research, 2020-02, Vol.22 (2), p.264-272</ispartof><rights>The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2019</rights><rights>The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-39e3bd07603c39e41c847a6971b346079d471e701793d85d6e82878dc4d45c983</citedby><cites>FETCH-LOGICAL-c474t-39e3bd07603c39e41c847a6971b346079d471e701793d85d6e82878dc4d45c983</cites><orcidid>0000-0002-1755-9826</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30759242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Keith, Rachel J</creatorcontrib><creatorcontrib>Fetterman, Jessica L</creatorcontrib><creatorcontrib>Orimoloye, Olusola A</creatorcontrib><creatorcontrib>Dardari, Zeina</creatorcontrib><creatorcontrib>Lorkiewicz, Pawel K</creatorcontrib><creatorcontrib>Hamburg, Naomi M</creatorcontrib><creatorcontrib>DeFilippis, Andrew P</creatorcontrib><creatorcontrib>Blaha, Michael J</creatorcontrib><creatorcontrib>Bhatnagar, Aruni</creatorcontrib><title>Characterization of Volatile Organic Compound Metabolites in Cigarette Smokers, Electronic Nicotine Device Users, Dual Users, and Nonusers of Tobacco</title><title>Nicotine &amp; tobacco research</title><addtitle>Nicotine Tob Res</addtitle><description>Abstract Introduction Limited research exists about the possible cardiovascular effects of electronic nicotine delivery systems (ENDS). We therefore sought to compare exposure to known or potentially cardiotoxic volatile organic compounds (VOCs) in ENDS users, smokers, and dual users. Methods A total of 371 individuals from the Cardiovascular Injury due to Tobacco Use study, a cross-sectional study of healthy participants aged 21–45 years, were categorized as nonusers of tobacco (n = 87), sole ENDS users (n = 17), cigarette smokers (n = 237), and dual users (n = 30) based on 30-day self-reported tobacco product use patterns. Participants provided urine samples for VOC and nicotine metabolite measurement. We assessed associations between tobacco product use and VOC metabolite measures using multivariable-adjusted linear regression models. Results Mean (SD) age of the population was 32 (±6.8) years, 55% men. Mean urinary cotinine level in nonusers of tobacco was 2.6 ng/mg creatinine, whereas cotinine levels were similar across all tobacco product use categories (851.6–910.9 ng/mg creatinine). In multivariable-adjusted models, sole ENDS users had higher levels of metabolites of acrolein, acrylamide, acrylonitrile, and xylene compared with nonusers of tobacco, but lower levels of most VOC metabolites compared with cigarette smokers or dual users. In direct comparison of cigarettes smokers and dual users, we found lower levels of metabolites of styrene and xylene in dual users. Conclusion Although sole ENDS use may be associated with lower VOC exposure compared to cigarette smoking, further study is required to determine the potential health effects of the higher levels of certain reactive aldehydes, including acrolein, in ENDS users compared with nonusers of tobacco. Implications ENDS use in conjunction with other tobacco products may not significantly reduce exposure to VOC, but sole use does generally reduce some VOC exposure and warrants more in-depth studies.</description><subject>Original Investigations</subject><issn>1462-2203</issn><issn>1469-994X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kb1OwzAUhS0EolBYeADkhQURsGM3jhcklJYfCehAi9gix7kthjSuHKcSvAfvi0uhgoXB8rnyd86VfBA6oOSUEsnOau_CeScx3UA7lCcykpI_bX7pOIpjwjpot2leSCBoSrdRhxHRkzGPd9BH9qyc0h6ceVfe2BrbCX60VdAV4KGbqtponNnZ3LZ1ie_Aq8JWxkODTY0zM1UOvAf8MLOv4JoTPKhAe2eXrnujrTc14D4sjAY8br6IfquqH61C5r2t2-W03DyyhdLa7qGtiaoa2P--u2h8ORhl19Ht8Oomu7iNNBfcR0wCK0oiEsJ00JzqlAuVSEELxhMiZMkFBUGokKxMe2UCaZyKtNS85D0tU9ZF56vceVvMoNQQvlJV-dyZmXJvuVUm__tSm-d8ahe5iKUgqQwBx6sA7WzTOJisvZTky3Ly4MtX5QT48Pe2NfrTRgCOVoBt5_8FfQIB3ZuT</recordid><startdate>20200206</startdate><enddate>20200206</enddate><creator>Keith, Rachel J</creator><creator>Fetterman, Jessica L</creator><creator>Orimoloye, Olusola A</creator><creator>Dardari, Zeina</creator><creator>Lorkiewicz, Pawel K</creator><creator>Hamburg, Naomi M</creator><creator>DeFilippis, Andrew P</creator><creator>Blaha, Michael J</creator><creator>Bhatnagar, Aruni</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1755-9826</orcidid></search><sort><creationdate>20200206</creationdate><title>Characterization of Volatile Organic Compound Metabolites in Cigarette Smokers, Electronic Nicotine Device Users, Dual Users, and Nonusers of Tobacco</title><author>Keith, Rachel J ; Fetterman, Jessica L ; Orimoloye, Olusola A ; Dardari, Zeina ; Lorkiewicz, Pawel K ; Hamburg, Naomi M ; DeFilippis, Andrew P ; Blaha, Michael J ; Bhatnagar, Aruni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-39e3bd07603c39e41c847a6971b346079d471e701793d85d6e82878dc4d45c983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Original Investigations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Keith, Rachel J</creatorcontrib><creatorcontrib>Fetterman, Jessica L</creatorcontrib><creatorcontrib>Orimoloye, Olusola A</creatorcontrib><creatorcontrib>Dardari, Zeina</creatorcontrib><creatorcontrib>Lorkiewicz, Pawel K</creatorcontrib><creatorcontrib>Hamburg, Naomi M</creatorcontrib><creatorcontrib>DeFilippis, Andrew P</creatorcontrib><creatorcontrib>Blaha, Michael J</creatorcontrib><creatorcontrib>Bhatnagar, Aruni</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nicotine &amp; tobacco research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Keith, Rachel J</au><au>Fetterman, Jessica L</au><au>Orimoloye, Olusola A</au><au>Dardari, Zeina</au><au>Lorkiewicz, Pawel K</au><au>Hamburg, Naomi M</au><au>DeFilippis, Andrew P</au><au>Blaha, Michael J</au><au>Bhatnagar, Aruni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of Volatile Organic Compound Metabolites in Cigarette Smokers, Electronic Nicotine Device Users, Dual Users, and Nonusers of Tobacco</atitle><jtitle>Nicotine &amp; tobacco research</jtitle><addtitle>Nicotine Tob Res</addtitle><date>2020-02-06</date><risdate>2020</risdate><volume>22</volume><issue>2</issue><spage>264</spage><epage>272</epage><pages>264-272</pages><issn>1462-2203</issn><eissn>1469-994X</eissn><abstract>Abstract Introduction Limited research exists about the possible cardiovascular effects of electronic nicotine delivery systems (ENDS). We therefore sought to compare exposure to known or potentially cardiotoxic volatile organic compounds (VOCs) in ENDS users, smokers, and dual users. Methods A total of 371 individuals from the Cardiovascular Injury due to Tobacco Use study, a cross-sectional study of healthy participants aged 21–45 years, were categorized as nonusers of tobacco (n = 87), sole ENDS users (n = 17), cigarette smokers (n = 237), and dual users (n = 30) based on 30-day self-reported tobacco product use patterns. Participants provided urine samples for VOC and nicotine metabolite measurement. We assessed associations between tobacco product use and VOC metabolite measures using multivariable-adjusted linear regression models. Results Mean (SD) age of the population was 32 (±6.8) years, 55% men. Mean urinary cotinine level in nonusers of tobacco was 2.6 ng/mg creatinine, whereas cotinine levels were similar across all tobacco product use categories (851.6–910.9 ng/mg creatinine). In multivariable-adjusted models, sole ENDS users had higher levels of metabolites of acrolein, acrylamide, acrylonitrile, and xylene compared with nonusers of tobacco, but lower levels of most VOC metabolites compared with cigarette smokers or dual users. In direct comparison of cigarettes smokers and dual users, we found lower levels of metabolites of styrene and xylene in dual users. Conclusion Although sole ENDS use may be associated with lower VOC exposure compared to cigarette smoking, further study is required to determine the potential health effects of the higher levels of certain reactive aldehydes, including acrolein, in ENDS users compared with nonusers of tobacco. Implications ENDS use in conjunction with other tobacco products may not significantly reduce exposure to VOC, but sole use does generally reduce some VOC exposure and warrants more in-depth studies.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>30759242</pmid><doi>10.1093/ntr/ntz021</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-1755-9826</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1462-2203
ispartof Nicotine & tobacco research, 2020-02, Vol.22 (2), p.264-272
issn 1462-2203
1469-994X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7297089
source Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Original Investigations
title Characterization of Volatile Organic Compound Metabolites in Cigarette Smokers, Electronic Nicotine Device Users, Dual Users, and Nonusers of Tobacco
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T05%3A13%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20Volatile%20Organic%20Compound%20Metabolites%20in%20Cigarette%20Smokers,%20Electronic%20Nicotine%20Device%20Users,%20Dual%20Users,%20and%20Nonusers%20of%20Tobacco&rft.jtitle=Nicotine%20&%20tobacco%20research&rft.au=Keith,%20Rachel%20J&rft.date=2020-02-06&rft.volume=22&rft.issue=2&rft.spage=264&rft.epage=272&rft.pages=264-272&rft.issn=1462-2203&rft.eissn=1469-994X&rft_id=info:doi/10.1093/ntr/ntz021&rft_dat=%3Coup_pubme%3E10.1093/ntr/ntz021%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/30759242&rft_oup_id=10.1093/ntr/ntz021&rfr_iscdi=true